Src inhibitors: genomics to therapeutics

Author： Sawyer Tomi Boyce Brendan Dalgarno David Iuliucci John

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.7, 2001-07, pp. : 1327-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Src Inhibitors and Angiogenesis

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2118-2128

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3193-3206

Bentham Science Publishers

Access to resources Recommend Favorite

Src Inhibitors as Potential Therapeutic Agents for Human Cancers

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-06 ,pp. : 681-687

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the discovery of Src kinase inhibitors

By Parang Keykavous Sun Gongqin

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1183-1207

Informa Healthcare

Access to resources Recommend Favorite

Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?

By Susva M. Missbach M. Green J.

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 489-495

Elsevier

Access to resources Recommend Favorite